Your Article Summary
See Latest ArticlesNarrative Review: Statin-Related Myopathy
Annals of Internal Medicine, 06/16/09
Joy TR et al. - Statin-related myopathy comprises myalgias, myositis, and rhabdomyolysis. Myalgias can affect up to 10% of persons prescribed statins, whereas rhabdomyolysis is rare. The mechanisms responsible for statin-related myopathy are unclear but may include decreased levels of coenzyme Q10, decreased bioavailability of isoprenoids, or mitochondrial dysfunction. Risk factors for myopathy include history of myopathy while receiving another lipid-lowering agent, family history of statin-related myopathy, high-dose statin therapy, increased age, female sex, and use of medications metabolized through cytochrome P450 3A4. Assessment of statin-related myopathy includes a search for other causes of creatine kinase elevation and myopathy. Management of statin-related myopathy can include switching agents or use of fluvastatin, low-dose rosuvastatin, nondaily dosing, and ezetimibe or bile acid–binding resins.
Related Articles
Inflammatory myopathies
Zeitschrift für Rheumatologie, 10/07/09
Relevance Score: 46%
Muscle carnitine deficiency: adult onset lipid storage myopathy with sensory neuropathy
Neurological Sciences, 10/07/09
Relevance Score: 45%
Vaccines as a trigger for myopathies
Lupus, 11/16/09
Relevance Score: 44%
Immune-mediated necrotizing myopathy associated with statins
Muscle & Nerve, 10/12/09
Relevance Score: 43%
Skeletal muscle cell MHC I expression: Implications for statin-induced myopathy
Muscle & Nerve, 10/12/09
Relevance Score: 43%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression
Anesthesiology, 12/17/09
In vitro detection and characterization of drug hypersensitivity using flow cytometry
Allergy, 12/16/09
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
Journal of the National Cancer Institute, 12/15/09
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Telmisartan/amlodipine: approved for high blood pressure
Formulary , 12/16/09
Clopidogrel Hypersensitivity: A Novel Multi-Day Outpatient Oral Desensitization Regimen
Annals of Pharmacotherapy, 12/16/09
Polypill: the evidence and the promise
Current Opinion in Lipidology, 12/15/09